About this Research Topic
Numerous evidences suggest the use of nanomaterials as tools that may prove helpful in the fight against viruses. Consequently, nanomaterials can be designed as novel delivery systems of drugs that both hinder viral replication or quench the viral-dependent deleterious inflammatory processes. Researchers are currently discovering several beneficial properties of nanomaterials aimed at translational medicine. By modulating the “nano-bio” interaction with nanoparticle surface chemistry, size and shape modifications, some previous concerns regarding potential toxicity may be overcome in favor of therapeutic or diagnostic potential. In addition, engineered nanomaterials can be developed in tracers that offer new insights into the molecular mechanisms of viral infection. Similarly, nanomaterials are in the forefront as vectors for specific vaccines. In addition to discrete properties useful for therapy and prophylaxis, nanomaterials can be engineered to detect viral particles in infected individuals.
This Research Topic will cover all these aspects of the utility of nanomaterial in nanomedicine, focusing on broad viral infections ranging from SARS-CoV-2 infection in COVID-19 pandemics to other diseases caused by previously encountered viruses (i.e. HPV, HIV).
We welcome papers on, but not limited to:
• nanomaterials for the diagnosis, therapy and vaccines in COVID-19 and other viral diseases
• nanomaterials for decreasing/stopping the infection-induced cytokine storm
• physicochemical and biological mechanisms of the interactions between nanomaterials and viral particles
• technological updates in the detection of viral particles using nanomaterials
• nanomaterials-based imaging approaches to detect viral particles in various tissues
• artificial intelligence and other computation tools to design in silico high-performance nanomaterials aimed at impairment of viral infections
• nanomaterials for healthcare biosensing applications to inflammation and cytokine release
• virus-directed nanotechnology based on biomolecules
• nanomaterials for repair and regeneration of tissues damaged by infections
The following type of articles will be accepted: Original Research, Brief Research Report, Data Report, Review, Mini Review, Perspective, Opinion, Policy and Practice Reviews
This Research Topic will cover all these aspects of the utility of nanomaterial in nanomedicine, focusing on broad viral infections ranging from SARS-CoV-2 infection in COVID-19 pandemics to other diseases caused by previously encountered viruses (i.e. HPV, HIV).
We welcome papers on, but not limited to:
• nanomaterials for the diagnosis, therapy and vaccines in COVID-19 and other viral diseases
• nanomaterials for decreasing/stopping the infection-induced cytokine storm
• physicochemical and biological mechanisms of the interactions between nanomaterials and viral particles
• technological updates in the detection of viral particles using nanomaterials
• nanomaterials-based imaging approaches to detect viral particles in various tissues
• artificial intelligence and other computation tools to design in silico high-performance nanomaterials aimed at impairment of viral infections
• nanomaterials for healthcare biosensing applications to inflammation and cytokine release
• virus-directed nanotechnology based on biomolecules
• nanomaterials for repair and regeneration of tissues damaged by infections
The following type of articles will be accepted: Original Research, Brief Research Report, Data Report, Review, Mini Review, Perspective, Opinion, Policy and Practice Reviews
Keywords: Nanomaterials, Virus, SarsCov2, Inflammation, cytokines
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
